BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35181483)

  • 1. The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION.
    Paitazoglou C; Meincke F; Bergmann MW; Eitel I; Fink T; Vireca E; Wohlmuth P; Veliqi E; Willems S; Markiewicz A; Grygier M
    Heart Rhythm; 2022 Jun; 19(6):917-926. PubMed ID: 35181483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
    Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Data of Procedural and Midterm Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Closure Between the WATCHMAN FLX and WATCHMAN 2.5 Devices - Insight From the OCEAN-LAAC Registry.
    Nakashima M; Yamamoto M; Sago M; Tanaka S; Chatani R; Asami M; Hachinohe D; Naganuma T; Ohno Y; Tani T; Okamatsu H; Mizutani K; Watanabe Y; Izumo M; Saji M; Mizuno S; Ueno H; Kubo S; Shirai S; Hayashida K;
    Circ J; 2024 Jun; 88(7):1187-1197. PubMed ID: 38763735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world experience with the new Watchman FLX device: Data from two high-volume Sicilian centers. The FLX-iEST registry.
    Vizzari G; Grasso C; Sardone A; Mazzone P; Laterra G; Frazzetto M; Sacchetta G; Micari A; Tamburino C; Contarini M
    Catheter Cardiovasc Interv; 2022 Jul; 100(1):154-160. PubMed ID: 35592941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device.
    Cruz-González I; Korsholm K; Trejo-Velasco B; Thambo JB; Mazzone P; Rioufol G; Grygier M; Möbius-Winkler S; Betts T; Meincke F; Sandri M; Schmidt B; Schmitz T; Nielsen-Kudsk JE
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2732-2741. PubMed ID: 33189641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
    Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study.
    Galea R; Mahmoudi K; Gräni C; Elhadad S; Huber AT; Heg D; Siontis GCM; Brugger N; Sebag F; Windecker S; Valgimigli M; Landolff Q; Roten L; Amabile N; Räber L
    Europace; 2022 Oct; 24(9):1441-1450. PubMed ID: 35253840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry.
    Berti S; De Caterina AR; Grasso C; Casu G; Giacchi G; Pagnotta P; Maremmani M; Mazzone P; Limite L; Tomassini F; Greco F; Romeo MR; Caramanno G; Fassini G; Geraci S; Chiarito M; Tondo C; Tamburino C; Contarini M
    Front Cardiovasc Med; 2023; 10():1115811. PubMed ID: 37180775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial.
    Doshi SK; Kar S; Sadhu A; Horton R; Osorio J; Ellis C; Stone J; Shah M; Dukkipati SR; Adler S; Nair DG; Kim J; Wazni O; Price MJ; Holmes DR; Shipley R; Christen T; Allocco DJ; Reddy VY;
    J Am Heart Assoc; 2023 Feb; 12(4):e026295. PubMed ID: 36789852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.
    Ellis CR; Jackson GG; Kanagasundram AN; Mansour M; Sutton B; Houle VM; Kar S; Doshi S; Osorio J
    Heart Rhythm; 2021 Jul; 18(7):1153-1161. PubMed ID: 33957090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracardiac echocardiography-guided implantation of the Watchman FLX left atrial appendage closure device.
    Turagam MK; Neuzil P; Petru J; Hala P; Mraz T; Baroch J; Lekesova V; Prokopova M; Dukkipati SR; Reddy VY
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):717-725. PubMed ID: 33533089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry.
    Bergmann MW; Betts TR; Sievert H; Schmidt B; Pokushalov E; Kische S; Schmitz T; Meincke F; Stein KM; Boersma LVA; Ince H
    EuroIntervention; 2017 Sep; 13(7):877-884. PubMed ID: 28606886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device.
    Korsholm K; Kramer A; Andersen A; Saw J; Nørgaard BL; Jensen JM; Nielsen-Kudsk JE
    J Interv Card Electrophysiol; 2023 Mar; 66(2):391-401. PubMed ID: 35951214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. True Efficacy of LAA Closure: Patient Outcomes on Long-term Single-Antiplatelet or No Therapy: Insights From the EWOLUTION Registry.
    Paitazoglou C; Bergmann MW; Ince H; Kische S; Romanov A; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Vireca E; Wohlmuth P; Boersma L;
    J Invasive Cardiol; 2022 May; 34(5):E348-E355. PubMed ID: 35501111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
    Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.